Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Aulin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Open Heart|September 1, 2025
Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort studyJulia Aulin, Angelo Modica, Lars Lindhagen, et al.
Journal of the American Heart Association|July 21, 2022
Serum Neurofilament Light Chain in Patients With Atrial FibrillationKarl Sjölin, Julia Aulin, Lars Wallentin, et al.
Scientific Reports|July 1, 2026
Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assayJulia Aulin, Asma Al-Grety, Karl Sjölin, et al.
Translational Stroke Research|September 3, 2025
Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic StrokeKarl Sjölin, Björn Röyter, Bianka Forgo, et al.
Journal of the American Heart Association|November 11, 2024
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral AnticoagulationJulia Aulin, Karl Sjölin, Johan Lindbäck, et al.
Circulation|July 24, 2024
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial FibrillationJulia Aulin, Karl Sjölin, Johan Lindbäck, et al.
American Heart Journal|December 19, 2015
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillationJulia Aulin, Agneta Siegbahn, Ziad Hijazi, et al.
Heart (British Cardiac Society)|February 4, 2016
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillationZiad Hijazi, Julia Aulin, Ulrika Andersson, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Open Heart|September 1, 2025
Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort studyJulia Aulin, Angelo Modica, Lars Lindhagen, et al.
Journal of the American Heart Association|July 21, 2022
Serum Neurofilament Light Chain in Patients With Atrial FibrillationKarl Sjölin, Julia Aulin, Lars Wallentin, et al.
Scientific Reports|July 1, 2026
Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assayJulia Aulin, Asma Al-Grety, Karl Sjölin, et al.
Translational Stroke Research|September 3, 2025
Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic StrokeKarl Sjölin, Björn Röyter, Bianka Forgo, et al.
Journal of the American Heart Association|November 11, 2024
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral AnticoagulationJulia Aulin, Karl Sjölin, Johan Lindbäck, et al.
Circulation|July 24, 2024
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial FibrillationJulia Aulin, Karl Sjölin, Johan Lindbäck, et al.
American Heart Journal|December 19, 2015
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillationJulia Aulin, Agneta Siegbahn, Ziad Hijazi, et al.
Heart (British Cardiac Society)|February 4, 2016
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillationZiad Hijazi, Julia Aulin, Ulrika Andersson, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
Pageof 2